GlassScriptPhysician profile
David G Sexton
NPI 1487658969
$1,635.90
in general payments reported to CMS, 2019-2025
20 companies · $318 in 2025
The $318 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $120 · 2021: $60.62 · 2022: $332 · 2023: $272 · 2024: $247 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $836.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $351.27 | 2021-2025 | |
| Stryker Corporation | $230.51 | 2021-2022 | |
| Olympus America INC. | $214.28 | 2019-2025 | Olympus, Hd Camera Head, Otoview |
| Regeneron Healthcare Solutions, INC. | $210.84 | 2022-2025 | Dupixent, Libtayo |
| Acclarent, INC | $148.44 | 2019-2023 | Acclarent Aera |
| Glaxosmithkline, LLC. | $95.81 | 2021-2025 | Nucala |
| Arbor Pharmaceuticals, INC. | $72.07 | 2019 | |
| Novartis Pharmaceuticals Corporation | $69.58 | 2019-2021 | |
| Optinose US, INC. | $35.93 | 2024 | |
| Integra Lifesciences Corporation | $28.94 | 2022-2024 | Trudi Probe, Inspira Air, Acclarent Aera |
| Hologic Sales and Service, LLC | $23.49 | 2023 | Coolseal Generator |
| Greer Laboratories, INC. | $21.91 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $19.24 | 2025 | Tezspire |
| Hologic INC | $19.01 | 2022 | |
| Intersect Ent, INC. | $18.10 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17.93 | 2025 | Stealthstation S8 Platform |
| Amgen INC. | $17.00 | 2025 | Tezspire |
| Merck Sharp & Dohme LLC | $16.45 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $13.50 | 2022 | |
| Resmed Corp | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sexton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.